FLASCO
- FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations | FDA September 19, 2024On September 19, 2024, the Food and Drug Administration approved amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) with carboplatin and pemetrexed for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations whose disease has progressed on or after treatment...
- FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma September 18, 2024On September 17, 2024, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with pemetrexed and platinum chemotherapy as first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM).
- FDA approves Kisqali with an aromatase inhibitor and Kisqali Femara Co-Pack for early high-risk breast cancer September 18, 2024On September 17, 2024, the Food and Drug Administration approved ribociclib (Kisqali, Novartis Pharmaceuticals Corporation) with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II and III early breast cancer at high risk of recurrence. Additionally, FDA also approved the ribociclib and...
- FDA approves atezolizumab and hyaluronidase-tqjs for subcutaneous injection September 13, 2024On September 12, 2024, the Food and Drug Administration approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) for subcutaneous injection for all the adult indications as the intravenous formulation of atezolizumab (Tecentriq, Genentech, Inc.), including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma (HCC), melanoma, and alveolar soft part sarcoma (ASPS)....
- Share the NCCS State of Cancer Survivorship Survey with Your Networks August 30, 2024The National Coalition for Cancer Survivorship (NCCS), a member of the Comprehensive Cancer Control National Partnership, has launched their 2024 State of Cancer Survivorship Survey, and we’re seeking your help to reach as many voices as possible. Why This Matters: The insights gathered through this survey will play a crucial role in shaping advocacy, support...
- Catch Up With COA | August Newsletter August 30, 2024It’s a presidential election year, and that means policy activity has ramped up on all fronts. While you’ve been busy caring for patients, COA has been working hard on your behalf. Check out the COA Mid-Year Update to stay up to date on all things cancer policy. Check out the COA Mid-Year Update to stay...
- ASCO Guideline Update Highlights the Importance of Early Integration of Palliative Care for Patients With Cancer August 30, 2024Growing awareness of the benefits of palliative care in patients with cancer has prompted ASCO to update its recommendations for clinicians, patients, caregivers, and health-care organizations on integrating palliative care in oncology. The updated guideline reinforces prior recommendations in the 2016 guidelines on early integration of palliative care in oncology while expanding the role of...
- Lung Cancer Disparities Lessen in South Florida’s Hispanic Communities August 30, 2024When it comes to cancer disparities, community may count. That’s the finding of a new study published Aug. 21 in the Journal of the National Cancer Institute, which was led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, together with the American Cancer Society. The study...
- Medicine’s Allies Excel In State Primary Election August 30, 2024Florida’s primary election on Tuesday was a success for medicine, with 89.7% of FMA PAC- endorsed candidates winning their races. From the Panhandle to Ocala, Orlando, Tampa,Sarasota, and South Florida, the FMA PAC Board members worked closely with legislative campaigns all summer, whether walking door-to-door for candidates, or hosting fundraisers and having coffee to deliver...
- Prescription for Change: Doctors Cast Their Votes for a Healthier Future August 28, 2024As oncologists, you are at the forefront of our community’s well-being. This election season, your vote can make a significant impact on the future of cancer care. Your daily encounters with patients provide you with a unique perspective on the healthcare system’s strengths and weaknesses. Voting is not just a civic duty; by exercising your...